Sponsored Content | Webinar | Advanced Visualization| August 29, 2017

WEBINAR: Multi-Modality 3-D Quantitative Imaging in Cancer Care: Clinical Value and Future Perspectives

This webinar is supported by an educational grant from Philips Healthcare

Liver cancer advanced imaging. Webinar will cover new advances for more precise targeting of Liver Cancer.

The webinar "Multi-Modality 3D Quantitative Imaging in Cancer Care: Clinical Value and Future Perspectives" focuses on the role of image analysis and artificial intelligence for image-guided, minimally invasive cancer therapies. It introduces the audience to the mechanisms and principles of image analysis, outlines the growing role of machine learning for the therapeutic algorithm and the decision making processes in interventional oncology.

The webinar took place Oct. 3, 2017. Watch the recorded archive version of this webinar by registering.

Register to watch the archive version of this webinar

 

Statement of Purpose
Liver cancer is the second most common cause of cancer-related death worldwide and most cases are diagnosed at intermediate to advanced stages of the disease, making most patients no longer amenable to surgical therapies. Minimally invasive, loco-regional image guided therapies, such as chemoembolization, have become the mainstay therapy for such patients. These image-guided interventions also gave birth to the new field of interventional oncology, a subspecialty of interventional radiology which is increasingly considered as the new and fourth pillar of cancer care (next to medical, surgical and radiation oncology). The explosive growth of such therapies requires new and more efficient intra- and post-procedural imaging solutions. This webinar will focus on the role of image analysis and artificial intelligence for image-guided, minimally invasive cancer therapies and introduce the audience to the mechanisms of action, principles of image analysis and the growing role of machine learning for the therapeutic algorithm and decision making in interventional oncology.

 

Learning Objectives
Upon completion of this activity, particpants will be able to:

• Summarize the principles and applications of image-guided minimally invasive tumor therapy.
• Describe the role of cancer imaging and multi-modality tumor tracking for local therapies of liver cancer.
• Review novel software-assisted 3-D quantitative tools to evaluate surrogate endpoints of therapeutic efficacy.
• Explain the growing role of machine learning in the automation and standardization of image analysis.

 

Intended Audience:
This activity is intended for oncologists, radiologist, nurse practitioners, biomedical engineers, and other clinicians interested in the management of liver cancer.

 

Presenter

Julius Chapiro, M.D., Ph.D.Julius Chapiro, M.D., Ph.D.
Research Scientist and Resident Physician
Yale School of Medicine

Dr. Chapiro is a research scientist at the Department of Radiology and Biomedical Imaging, Yale University School of Medicine. After graduating from the University of Leipzig and upon completion of his research thesis at the Justus-Liebig University in Giessen, he served as a postdoctoral fellow in interventional oncology at The Johns Hopkins Hospital and then as radiology resident at the Department of Radiology, Charité University Hospital in Berlin.

Dr. Chapiro works on the development of novel imaging biomarkers, tumor response criteria, staging systems and molecular imaging techniques for image-guided liver cancer therapies. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence and machine learning solutions for the assessment of liver cancer. His basic research interest mainly focuses on tumor metabolism and immuno-oncology. With over 50 peer-reviewed publications, book chapters and news articles, Dr. Chapiro advocates the element of personalized medicine in interventional oncology, which is the most rapidly growing field in interventional radiology practice. Creating innovative and clinically practicable solutions and translating them from concept to practice has been his central mission for the past five years.  He is the co-director of the Yale Radiology Research laboratory.

 

Register to watch the archive version of this webinar

Related Content

During the virtual 106th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 29 to Dec. 5, Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of AI-Rad Companion Organs RT, the latest Siemens Healthineers artificial intelligence-based software assistant in the AI-Rad Companion family.
News | Artificial Intelligence | November 30, 2020
November 30, 2020 — During the virtual 106th Scientific Assembly and Annual Meeting of the...
James P. Borgstede, M.D.

James P. Borgstede, M.D.

News | Radiology Business | November 29, 2020
November 29, 2020 — RSNA President...
Chest CT images in a 34-year-old man with fever for 4 days. Positive result of reverse-transcription polymerase chain reaction assay for severe acute respiratory syndrome coronavirus 2 using a swab sample was obtained on February 8, 2020. Dates of examination are shown on images. A, Chest CT scan with magnification of lesions in coronal and sagittal planes shows a nodule with reversed halo sign in left lower lobe (box) at the early stage of the pneumonia. B, Chest CT scans in different axial planes and coro

Chest CT images in a 34-year-old man with fever for 4 days. Positive result of reverse-transcription polymerase chain reaction assay for severe acute respiratory syndrome coronavirus 2 using a swab sample was obtained on February 8, 2020. Dates of examination are shown on images. A, Chest CT scan with magnification of lesions in coronal and sagittal planes shows a nodule with reversed halo sign in left lower lobe (box) at the early stage of the pneumonia. B, Chest CT scans in different axial planes and coronal reconstruction show bilateral multifocal ground-glass opacities. The nodular opacity resolved.

News | Coronavirus (COVID-19) | November 29, 2020
November 29, 2020 — The Radiological Society of North America (...
ASG well positioned for growth as healthcare marketplace continues to evolve 

Allan Klotsche

News | Radiology Imaging | November 24, 2020
November 24, 2020 — Alpha Source Group (ASG), a comprehensive next-generation services partner, has named...
New multimodality virtual imaging command center enables real-time, remote collaboration to broaden expertise between technologists, radiologists and imaging operations teams across multiple sites via private, secure telepresence capabilities
News | Information Technology | November 24, 2020
November 24, 2020 — Philips announced commercial launch of the industry’s first vendor-neutral, multimodality, radiol
Fovia Ai, Inc., a subsidiary of Fovia, Inc., a world leader in advanced visualization for nearly two decades and a preeminent provider of zero-footprint, cloud-based imaging SDKs, today announced that it will be showcasing the continued expansion of its artificial intelligence product portfolio together with Fovia’s advanced imaging solutions at the first Virtual Radiology Society of North America (RSNA) Conference, November 29 - December 5.
News | Artificial Intelligence | November 24, 2020
November 24, 2020 — Fovia Ai, Inc., a subsidiary of Fovia, Inc., a world leader in...
Videos | Coronavirus (COVID-19) | November 20, 2020
This video shows a computed tomography (CT) scroll through showing bowel ischemia and perforation (see arrows) due to